Results · Apr-Jun 2026
Aspira Pathlab & Diagnostics Q1 FY27 results
Sales grew 18% to ₹6.2 crore from ₹5.2 crore in Apr-Jun 2025.
Operating profit fell 58% to ₹0.34 crore, an operating margin of 5.6% (down 10.1 points from a year ago).
Net profit turned into a loss of ₹0.04 crore, from a profit of ₹0.47 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −5%, loss narrows.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 6.2 | 5.2 | +18% |
| Operating profit (EBITDA) | 0.3 | 0.8 | −58% |
| Operating margin | 5.6% | 15.6% | −10.1 pts |
| Net profit | -0.0 | 0.5 | swings to a loss |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.